Jacobs B, Gasperi C, Kalluri S, Al-Najjar R, McKeon M, Else J
Cell Rep Med. 2024; 6(1):101733.
PMID: 39708811
PMC: 11866449.
DOI: 10.1016/j.xcrm.2024.101733.
Asmis R, Medrano M, Chase Huizar C, Griffith W, Forsthuber T
Nutrients. 2024; 16(3).
PMID: 38337633
PMC: 10856865.
DOI: 10.3390/nu16030348.
El Mahdaoui S, Hansen M, von Essen M, Hvalkof V, Holm Hansen R, Mahler M
Ann Clin Transl Neurol. 2024; 11(4):926-937.
PMID: 38332555
PMC: 11021659.
DOI: 10.1002/acn3.52009.
Zhou W, Graner M, Beseler C, Domashevich T, Selva S, Webster G
Clin Immunol. 2023; 256:109801.
PMID: 37816415
PMC: 11830478.
DOI: 10.1016/j.clim.2023.109801.
Laaker C, Baenen C, Kovacs K, Sandor M, Fabry Z
Front Immunol. 2023; 14:1233908.
PMID: 37662908
PMC: 10471710.
DOI: 10.3389/fimmu.2023.1233908.
Continued dysregulation of the B cell lineage promotes multiple sclerosis activity despite disease modifying therapies.
Londono A, Mora C
F1000Res. 2023; 10:1305.
PMID: 37655229
PMC: 10467621.
DOI: 10.12688/f1000research.74506.2.
The pathogenesis of multiple sclerosis: a series of unfortunate events.
van Noort J, Baker D, Kipp M, Amor S
Clin Exp Immunol. 2023; 214(1):1-17.
PMID: 37410892
PMC: 10711360.
DOI: 10.1093/cei/uxad075.
ViCloD, an interactive web tool for visualizing B cell repertoires and analyzing intraclonal diversities: application to human B-cell tumors.
Jeusset L, Abdollahi N, Verny T, Armand M, De Septenville A, Davi F
NAR Genom Bioinform. 2023; 5(2):lqad064.
PMID: 37388820
PMC: 10304752.
DOI: 10.1093/nargab/lqad064.
Effect of Ocrelizumab on B- and T-Cell Receptor Repertoire Diversity in Patients With Relapsing Multiple Sclerosis From the Randomized Phase III OPERA Trial.
Laurent S, Strauli N, Eggers E, Wu H, Michel B, Demuth S
Neurol Neuroimmunol Neuroinflamm. 2023; 10(4).
PMID: 37094998
PMC: 10136682.
DOI: 10.1212/NXI.0000000000200118.
Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic.
De Seze J, Maillart E, Gueguen A, Laplaud D, Michel L, Thouvenot E
Front Immunol. 2023; 14:1004795.
PMID: 37033984
PMC: 10076836.
DOI: 10.3389/fimmu.2023.1004795.
Multiple Sclerosis Is Associated with Immunoglobulin Germline Gene Variation of Transitional B Cells.
Lomakin Y, Ovchinnikova L, Zakharova M, Ivanova M, Simaniv T, Kabilov M
Acta Naturae. 2023; 14(4):84-93.
PMID: 36694905
PMC: 9844083.
DOI: 10.32607/actanaturae.11794.
B-Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
von Niederhausern V, Ruder J, Ghraichy M, Jelcic I, Muller A, Schanz U
Neurol Neuroimmunol Neuroinflamm. 2022; 9(6).
PMID: 36229189
PMC: 9562041.
DOI: 10.1212/NXI.0000000000200027.
Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2.
Murayama A, Sugaya K, Hara M, Kawazoe T, Tobisawa S, Nakajima H
Intern Med. 2022; 62(11):1659-1663.
PMID: 36223927
PMC: 10292997.
DOI: 10.2169/internalmedicine.9670-22.
The CXCL13/CXCR5 Immune Axis in Health and Disease-Implications for Intrathecal B Cell Activities in Neuroinflammation.
Harrer C, Otto F, Radlberger R, Moser T, Pilz G, Wipfler P
Cells. 2022; 11(17).
PMID: 36078057
PMC: 9454489.
DOI: 10.3390/cells11172649.
Ocrelizumab in Patients with Active Primary Progressive Multiple Sclerosis: Clinical Outcomes and Immune Markers of Treatment Response.
Boziki M, Bakirtzis C, Sintila S, Kesidou E, Gounari E, Ioakimidou A
Cells. 2022; 11(12).
PMID: 35741088
PMC: 9222195.
DOI: 10.3390/cells11121959.
Breaching Brain Barriers: B Cell Migration in Multiple Sclerosis.
Rodriguez-Mogeda C, Rodriguez-Lorenzo S, Attia J, van Horssen J, Witte M, de Vries H
Biomolecules. 2022; 12(6).
PMID: 35740925
PMC: 9221446.
DOI: 10.3390/biom12060800.
Cladribine Tablets for Relapsing-Remitting Multiple Sclerosis: A Clinician's Review.
Giovannoni G, Mathews J
Neurol Ther. 2022; 11(2):571-595.
PMID: 35318617
PMC: 8940595.
DOI: 10.1007/s40120-022-00339-7.
Intrathecally Expanding B Cell Clones in Herpes Simplex Encephalitis: A Case Report.
Coronel-Castello S, Lepennetier G, Diddens J, Friedrich V, Pfaller M, Hemmer B
Neurol Ther. 2022; 11(2):905-913.
PMID: 35124795
PMC: 9095784.
DOI: 10.1007/s40120-022-00330-2.
Role and Relevance of Cerebrospinal Fluid Cells in Diagnostics and Research: State-of-the-Art and Underutilized Opportunities.
Otto F, Harrer C, Pilz G, Wipfler P, Harrer A
Diagnostics (Basel). 2022; 12(1).
PMID: 35054246
PMC: 8774636.
DOI: 10.3390/diagnostics12010079.
Skewing of the antibody repertoire in cerebrospinal fluid B cells from healthy controls and patients with schizophrenia.
Husain-Krautter S, Lee J, Vos D, Gallego J, Malhotra A, Rothstein T
Behav Brain Res. 2022; 422:113743.
PMID: 35007628
PMC: 9248756.
DOI: 10.1016/j.bbr.2022.113743.